Effects of different operations on cirrhotic portal hypertensive liver in rats

World Chinese Journal of Digestology

Volumn 12, Issue 3, 2004, Pages 689-693

  Xu, Xin Bao ^a   Cai, Jing Xiu ^b   Dong, Jia Hong ^b   He, Zhen Ping ^b   Han, Ben Li ^b   Leng, Xi Sheng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBON TETRACHLORIDE; LIPID PEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER CIRRHOSIS; LIVER MITOCHONDRION; MESENTERIOCAVAL ANASTOMOSIS; MITOCHONDRIAL RESPIRATION; MORTALITY; NONHUMAN; PORTAAZYGOUS DISCONNECTION; PORTAL HYPERTENSION; RAT; SPLENOCAVAL SHUNT; SURGICAL TECHNIQUE; ULTRASTRUCTURE;

EID: 2442552145     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H, Moriwaki H. Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition 2002;18:229-234
2. Perseghin G, Mazzaferro V, Benedini S, Pulvirenti A, Coppa J, Regalia E, Luzi L. Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy. Am J Clin Nutr 2002;76:541-548
3. Poon RT, Fan ST. Clinical implications of altered energy metabolism in patients with cirrhosis. Nutrition 2002;18:283-284
4. Cheng XD, Jiang XC, Liu YB, Peng CH, Xu B, Peng SY. Effect of ischemic preconditioning on P-selectin expression in hepatocytes of rats with cirrhotic ischemia-reperfusion injury. World J Gastroenterol 2003;9:2289-2292
5. Lei DX, Peng CH, Peng SY, Jiang XC, Wu YL, Shen HW. Safe upper limit of intermittent hepatic inflow occlusion for liver resection in cirrhotic rats. World J Gastroenterol 2001;7:713-717
6. Mann DV, Lam WW, Hjelm NM, So NM, Yeung DK, Metreweli C, Lau WY. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology 2001;34:557-565
7. Froomes PR, Ghabrial H, Morgan DJ, Angus PW. The effect of oxygen supplementation on the arterial ketone body ratio in human cirrhosis. Digestion 2002;66:257-261
8. Spahr L, Negro F, Leandro G, Marinescu O, Goodman KJ, Rubbia-Brandt L, Jordan M, Hadengue A. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis. Med Sci Monit 2003;9:CR6-11
9. Tappy L, Schneiter P, Chiolero R, Bettschart V, Gillet M. Effects of a glucose meal on energy metabolism in patients with cirrhosis before and after liver transplantation. Arch Surg 2001;136:80-84.
10. Lu G, Shimizu I, Cui X, Itonaga M, Tamaki K, Fukuno H, Inoue H, Honda H, Ito S. Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes, and hepatic stellate cells. J Med Invest 2002;49:172-181
11. Guo MZ, Li XS, Shen DM, Guan XQ, Xu HR, Gao J. Effect of Rhein on the development of hepatic fibrosis in rats. Article in Chinese. Zhonghua Ganzangbing Zazhi 2003;11:26-29
12. Fiorelli G, De Feo TM, Duca L, Tavazzi D, Nava I, Fargion S, Cappellini MD. Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. Eur J Clin Invest 2002;32 (Suppl 1):21-27
13. Liu DY, Peng ZH, Qiu GQ, Zhou CZ. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World J Gastroenterol 2003;9:1859-1862
14. Gonzalez-Reimers E, Lopez-Lirola A, Olivera RM, Santolaria-Fernandez F, Galindo-Martin L, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Martinez-Riera A. Effects of protein deficiency on liver trace elements and antioxidant activity in carbon tetrachloride-induced liver cirrhosis. Biol Trace Elem Res 2003;93:127-140
15. Lata J, Hulek P, Vanasek T. Management of acute variceal bleeding. Dig Dis 2003;21:6-15
16. Patch D, Dagher L. Acute variceal bleeding: general management. World J Gastroenterol 2001;7:466-475
17. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003;300:1140-1142
18. Vyzantiadis T, Theodoridou S, Giouleme O, Harsoulis P, Evgenidis N, Vyzantiadis A. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis. Hepatogastroenterology 2003;50:814-816
19. Wang XZ, Chen ZX, Zhang LJ, Chen YX, Li D, Chen FL, Huang YH. Expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor and its intervention by interleukin-10 in experimental hepatic fibrosis. World J Gastroenterol 2003;9:1287-1291
20. Glanemann M, Vollmar B, Nussler AK, Schaefer T, Neuhaus P, Menger MD. Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 2003;38:59-66
21. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA. Altered liver gene expression in CC14-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 2002;34:242-252
22. Perez R, Castilla-Cortazar I, Nunez M, Prado A, Mirpuri E, Garcia M, Gonzalez Baron S, Picardi A. IGF-I does not improve fat malabsorption in cirrhotic rats. J Physiol Biochem 2001;57:59-60
23. Fan ZR, Yang DH, Cui J, Qin HR, Huang CC. Expression of insulin like growth factor II and its receptor in hepatocellular carcinogenesis. World J Gastroenterol 2001;7:285-288
24. Muguerza B, Castilla-Cortazar I, Garcia M, Quiroga J, Santidrian S, Prieto J. Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim Biophys Acta 2001;1536:185-195
25. Chandrashekhar R, Murase GN, Subbotin VM, Uemura T, Nalesnik M, Demetris AJ, Fung JJ, Starzl TE. Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors. J Hepatol 2002;37:340-348
26. Chalasani N, Gorski JC, Patel NH, Hall SD, Galinsky RE. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts. Hepatology 2001;34:1103-1108
27. Geier A, Gartung C, Dietrich CG, Wasmuth HE, Reinartz P, Matern S. Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: Influence of hepatic, metabolism versus portosystemic shunts on a patient complicated with HCC. World J Gastroenterol 2003;9:2681-2685
28. 4-induced liver fibrosis in rats and its probable molecular mechanisms. World J Gastroenterol 2003;9:1559-1562
29. Brandao ML, Roselino JE, Piccinato CE, Cherri J. Mitochondrial alterations in skeletal muscle submitted to total ischemia. J Surg Res 2003;110:235-240
30. Cheng XD, Jiang XC, Liu YB, Peng CH, Xu B, Peng SY. Effect of ischemic preconditioning on P-selectin expression in hepatocytes of rats with cirrhotic ischemia-reperfusion injury. World J Gastroenterol 2003;9:2289-2292
31. Matheson PJ, Hurt RT, Mittel OF, Wilson MA, Spain DA, Garrison RN. Immune-enhancing enteral diet increases blood flow and proinflammatory cytokines in the rat ileum. J Surg Res 2003;110:360-370
32. Singh K, Ahluwalia P. Studies on the effect of monosodium glutamate [MSG] administration on some antioxidant enzymes in the arterial tissue of adult male mice. J Nutr Sci Vitaminol (Tokyo) 2003;49:145-148
33. Du WD, Yuan ZR, Sun J, Tang JX, Cheng AQ, Shen DM, Huang CJ, Song XH, Yu XF, Zheng SB. Therapeutic efficacy of high-dose vitamin C on acute pancreatitis and its potential mechanisms. World J Gastroenterol 2003;9:2565-2569
34. Park BK, Chung JB, Lee JH, Suh JH, Park SW, Song SY, Kim H, Kim KH, Kang JK. Role of oxygen free radicals in patients with acute pancreatitis. World J Gastroenterol 2003;9:2266-2269
35. Zhang H, Chen J, Kaiser GM, Mapudengo O, Zhang J, Exton MS, Song E. The value of partial splenic autotransplantation in patients with portal hypertension: a prospective randomized study. Arch Surg 2002;137:89-93
36. Mercado MA, Orozco H, Ramirez-Cisneros FJ, Hinojosa CA, Plata JJ, Alvarez-Tostado J. Diminished morbidity and mortality in portal hypertension surgery: relocation in the therapeutic armamentarium. J Gastrointest Surg 2001;5:499-502
37. Glanemann M, Vollmar B, Nussler AK, Schaefer T, Neuhaus P, Menger MD. Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J Hepatol 2003;38:59-66
38. Taylor RM, Bjarnason I, Cheeseman P, Davenport M, Baker AJ, Mieli-Vergani G, Dhawan A. Intestinal permeability and absorptive capacity in children with portal hypertension. Scand J Gastroenterol 2002;37:807-811
39. Wheeler MD, Katuna M, Smutney OM, Froh M, Dikalova A, Mason RP, Samulski RJ, Thurman RG. Comparison of the effect of adenoviral delivery of three superoxide dismutase genes against hepatic ischemia-reperfusion injury. Hum Gene Ther 2001;12:2167-2177
40. Yamaoka Y, Sato M, Kimura K, Takasan H, Ozawa K. Role of portal venous blood supply from the pancreas in maintaining hepatic functional reserve. Appraisal of Warren's shunt operation. Arch Surg 1978;113:981-985
41. Dasarathy S, Mullen KD, Conjeevaram HS, Kaminsky-Russ K, Wills LA, McCullough AJ. Preservation of portal pressure improves growth and metabolic profile in the male portacaval-shunted rat. Dig Dis Sci 2002;47:1936-1942
42. Iwase M, Ogata H, Tashiro K, Tsuji H, Yoshinari M. Portal blood flow and glucose tolerance or peripheral insulin and glucagon concentrations in patients with liver cirrhosis. Pancreas 2002;24:109-110
43. Yang LQ, Li SJ, Cao YF, Man XB, Yu WF, Wang HY, Wu MC. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J Gastroenterol 2003;9:359-363
44. Song G, Dhodda VK, Blei AT, Dempsey RJ, Rao VL. GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 2002;68:730-737
45. Schepke M, Sauerbruch T. Transjugular portosystemic stent shunt in treatment of liver diseases. World J Gastroenterol 2001;7:170-174
46. Wong LL, Lorenzo C, Limm WM, Wong LM. Splenorenal shunt: an ideal procedure in the Pacific. Arch Surg 2002;137:1125-1129